Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

• José M. Pérez de la Lastra,
• Uttpal Anand,
• Sergio González-Acosta,
• Manuel R. López,
• Abhijit Dey,
• Elza Bontempi,
• Antonio Morales delaNuez

Affiliations

José M. Pérez de la Lastra

Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain

Uttpal Anand

CytoGene Research & Development LLP, Barabanki, Uttar Pradesh, India

Sergio González-Acosta

Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain

Manuel R. López

Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain

Abhijit Dey

Department of Life Sciences, Presidency University, Kolkata, India

Elza Bontempi

National Interuniversity Consortium of Materials Science and Technology (INSTM) and Chemistry for Technologies Laboratory, Department of Mechanical and Industrial Engineering, University of Brescia, Brescia, Italy

Antonio Morales delaNuez

Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain